RecruitingNot ApplicableNCT06734286

Working Memory Training in Patients with Mild Cognitive Impairment

CogMed Intervention Targeting Working Memory in Patients with Mild Cognitive Impairment


Sponsor

St. Joseph's Hospital and Medical Center, Phoenix

Enrollment

10 participants

Start Date

Sep 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a computer-based brain training program designed to improve working memory in people with mild cognitive impairment (MCI) — an early stage of memory and thinking difficulties that may precede dementia. **You may be eligible if...** - You are 50 years of age or older - You have been diagnosed with mild cognitive impairment (MCI) - You have access to the internet via a computer - You can read and speak English, or have a family member who can assist with translation - Your vision and hearing are good enough to complete the study tasks **You may NOT be eligible if...** - Your score on the Mini Mental State Exam (MMSE) is below 19, or you have been diagnosed with moderate or severe dementia - You have another condition that makes participation impractical Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCogMed

CogMed which is a computerized working memory training program developed by Karolinska University.


Locations(1)

Barrow Neurological Institute, Division of Alzheimer's Disease

Phoenix, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06734286


Related Trials